[New trends in the treatment of trophic sequelae post-phlebitic syndrome].
Authors analyses most recent concepts on pathogenesis of trophic changes in post-phlebitic syndrome: particularly they consider the role of extravascular fibrin deposition, in patients with depressed plasmatic fibrinolytic activity. In this patients, according to recent reports, it seems useful a fibrinolytic therapy to improve trophic conditions of the post-phlebitic limb, particularly in respect to dermatoliposclerosis. Authors refer their experience on a double blind study with stanozolol an anabolizing steroid with fibrinolytic activity: in all treated patients good clinical results were obtained; however no enhancement of plasmatic fibrinolytic activity was demonstrated.
D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D002986:Clinical Trials as Topic; D005121:Extremities / Q000098:blood supply*; D005342:Fibrinolysis; D006801:Humans; D008875:Middle Aged; D010689:Phlebitis / Q000097:blood / Q000150:complications*; D011897:Random Allocation; D013197:Stanozolol / Q000627:therapeutic use*; D013577:Syndrome
D013197:Stanozolol
Nuovi orientamenti nel trattamento delle sequele trofiche della sindrome post-flebitica.